PTK2 and cancer: We found that cell proliferation was decreased in FAK/25aa and the FAK/25aaR385A/S386A transfectants compared to mock and the FAK/25aaE380A/K381A/Q382A-transfected cells (Fig. 4b), implicating the β4 integrin/FAK complex in promoting cancer cell proliferation.